Overview Quote
Stock Activity
| Day Low - High | 8.97 - 9.14 |
| 52wk Low - High | 4.79 - 9.18 |
| Previous Close | 9.04 |
| Avg. Volume | 19,466,048 |
| Industry | MED PRODUCTS |
| Market Cap | 12.35 B |
| Div - Yield | 0.00 - 0.00 |
| Beta | 1.17 |
| PE (Forward) | 13.55 |
| Current Year Est. | 0.67 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
175 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Company Description
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.16 | 0.16 | 0.67 | 0.73 |
| Number of Estimates | 13 | 13 | 12 | 13 |
| Low Estimate | 0.15 | 0.15 | 0.66 | 0.69 |
| High Estimate | 0.17 | 0.17 | 0.68 | NA |
| Year Ago EPS | 0.17 | 0.16 | 0.66 | 0.67 |
| EPS Growth | -5.43% | 1.44% | 1.77% | 9.14% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| BOSTON SCIENTIF | BSX | 9.10 | ![]() |
![]() |
| CONCEPTUS INC | CPTS | 30.92 | ![]() |
![]() |
| ATRICURE INC | ATRC | 9.07 | ![]() |
![]() |
| CYTOSORBENTS CP | CTSO | 0.12 | ![]() |
![]() |
| INVIVO THERAPT | NVIV | 2.89 | ![]() |
![]() |
| TRANS1 INC | TSON | 1.70 | ![]() |
![]() |
| ABAXIS INC | ABAX | 45.35 | ![]() |
![]() |
| ADVAXIS INC | ADXS | 0.05 | ![]() |
![]() |
| ALERE INC | ALR | 26.30 | ![]() |
![]() |
| BAXTER INTL | BAX | 72.94 | ![]() |
![]() |
Sector:Medical>> Industry:MED PRODUCTS
Zacks Commentary
Alleged Patent Infringement by BSX
May 17, 2013
Study for STJ's Latest EnligHTN
May 15, 2013
Good News for STJ's Durata
May 14, 2013
St. Jude's New Quadra Study
May 07, 2013
BSX Beats Y/Y Earnings, Guides Low
Apr 25, 2013
Stryker's 1Q Earnings Beat Est.; Sales Lag
Apr 25, 2013
BSX Precision System Now in U.S.
Apr 15, 2013
MDT to Grow Endovascular Biz Globally
Apr 08, 2013
Financials
| EPS TTM | 0.67 |
| Sales | 7,249 |
| Net Income | -4,423 |
| Price/Earnings | 13.58 |
| Price/Book | 1.90 |
| Price/Cash Flow | 2.05 |
| Price/Sales | 1.73 |
News
Cramer`s Top Stock Picks: BSX BAX FB - TheStreet.com
May 18, 2013
Boston Scientific Presents Clinical Data at Digestive Disease WeekA? - Pr Newswire
May 17, 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 - Pr Newswire
May 17, 2013
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 - Pr Newswire Europe
May 17, 2013
Insider Trading News for NetApp, Facebook, Advanced Micro Devices, Boston Scientific, Hess, and Cliffs Natural Resources - Pr Newswire
May 17, 2013
Boston Scientific (BSX) Showing Bullish Technicals With Resistance At $9.41 - Freshbrewedmedia
May 16, 2013
Shares of Boston Scientific Are Moving Lower on 1.6x Above-Average Volume (BSX) - Financial News Network Online - Unusual Volume
May 16, 2013
UPDATE: Stifel Nicolaus Raises PT on Boston Scientific Following HRS Meeting, Management Q&A - Benzinga
May 16, 2013
Broker Recommendations
| Current ABR | 2.44 |
| ABR (Last Week) | 2.41 |
| # of recs in ABR | 18 |
| Average Target Price | 7.92 |
| Industry Rank by ABR | 175 out of 265 |
| Rank in Industry | 6 out of 72 |

